Nektar In Renal Cell Carcinoma: An Overview
koto_feja/E+ via Getty Images
Nektar (NKTR) hasn’t been doing too well lately, despite a data-rich year ahead; and the fall started after poor revenue figures from February, as well as from May. However, it doesn’t have approved products any longer; in…
